Amarin Corp Plc (AMRN)

[sharinky]

Insurance companies in the US are short sighted. They look at their out of pocket costs in the current year. The patient may not be their patient next year when that heart attack may happen. They do not always think long term and they are just slow to change.

Yes, some insurances commercial insurances are started to change their view of Vascepa. We need Vascepa to be the only drug available for the indication. The government regulated insurances, Medicaid and Medicare are slow to change and will need actual approval and a real indication to get this covered with reasonable copay. Generic lovaza scripts are still what they are because State Medicaid plans are not covering Vascepa, they are still going with the cheaper alternative. Right now there is still in inequity in the system. Those that can afford the drugs are getting them and those that can't are getting the unproven alternative.

Once we get approval, there will be no alternative. Insurances, whether commercial or government will need to cover the preventive drug with a reasonable copay. FDA approval will speed up the process of better coverage for everyone.